Sabrient Leaders In Investment Research HEALTH CARE PROPERTY INVESTORS. Company Profile. Sabrient Analysis. Stock Fundamentals as of January 19, 2010

Similar documents
Sabrient Leaders In Investment Research RESEARCH IN MOTION LTD. Company Profile. Sabrient Analysis. Stock Fundamentals as of January 19, 2010

Sabrient Leaders In Investment Research CNH GLOBAL NV (ADR) Company Profile. Sabrient Analysis. Stock Fundamentals as of January 19, 2010

Sabrient Leaders In Investment Research CYANOTECH HOLD RATING. Company Profile. Sabrient Analysis. Stock Fundamentals as of May 7, 2018

Sabrient Leaders In Investment Research ENERSIS SA (ADR) Company Profile. Sabrient Analysis. Stock Fundamentals as of December 14, 2009

Sabrient Leaders In Investment Research PSYCHIATRIC SOLUTIONS INC. Company Profile. Sabrient Analysis. Stock Fundamentals as of July 27, 2009

Sabrient Leaders In Investment Research MEADWESTVACO CORP SELL RATING. Company Profile. Sabrient Analysis. Stock Fundamentals as of September 14, 2009

Last week's rating: C Marketperform Percentile Ranking: 60 Data as of 10/12/2018

Last week's rating: C Marketperform Percentile Ranking: 53 Data as of 07/06/2018

W H I T E P A P E R. Sabrient Multi-cap Insider/Analyst Quant-Weighted Index DAVID BROWN CHIEF MARKET STRATEGIST

Trailing PE Forward PE Hold 6 Analysts. 1-Year Return: 3.5% 5-Year Return: 21.4%

Aspiriant Risk-Managed Equity Allocation Fund RMEAX Q4 2018

Trailing PE Forward PE Buy 2 Analysts. 1-Year Return: -39.7% 5-Year Return: --

The Benefits of Dynamic Factor Weights

The Compelling Case for Value

Identifying a defensive strategy

THIS WEEK IN EARNINGS

Last week's rating: A Strongly Outperform Percentile Ranking: 1 Data as of 01/19/2018. Sample

Analyst's Notes. Argus Recommendations

Market Capitalization $5.4 Billion. Weekly Price: (US$) SMA (50) SMA (100) 1 Year 2 Years BUY HOLD BUY HOLD BUY

Blended share-weighted earnings for the S&P 500 for Q stand at $199.8B for a second consecutive week.

Equity Rating and Report

Weekly Market Commentary

Playing The Bull Market s Final Inning(s)

FDM First Trust Dow Jones Select MicroCap Index Fund

Trailing PE Forward PE 8.5. Buy 5 Analysts. 1-Year Return: -39.3% 5-Year Return: -91.2%

Dividend Growth as a Defensive Equity Strategy August 24, 2012

FRI First Trust S&P REIT Index Fund

Estimated share-weighted earnings for the S&P 500 for Q stand at $184.2B this week, slightly below last week s $184.3B.

User Guide for Schwab Equity Ratings Report

About Schwab Equity Ratings International

Analyst's Notes. Argus Recommendations

Estimated share-weighted earnings for the S&P 500 for Q stand at $242.1B this week, above last week s $242.0B.

Analyst's Notes. Argus Recommendations

Wells Fargo & Company

Nuance Concentrated Value Composite Perspectives

BROAD COMMODITY INDEX

Attractiveness Ratings for The Approved Wright Investment List

Trailing PE 2.4. Forward PE 9.2. Buy 7 Analysts. 1-Year Return: -21.0% 5-Year Return: -27.3%

52-Week High Trailing PE Week Low Forward PE Buy 17 Analysts. 1-Year Return: 33.6% 5-Year Return: 36.

Trailing PE 8.9. Forward PE 8.0. Buy 1 Analyst. 1-Year Return: -- 5-Year Return: --

Hudson City Bancorp, Inc.

Trailing PE Forward PE -- NA 0 Analysts. 1-Year Return: 0.0% 5-Year Return: -78.1%

Third quarter earnings are expected to increase 8.4% from Q Excluding the Energy sector, the earnings growth estimate declines to 6.1%.

Healthways Inc. OUTPERFORM ZACKS CONSENSUS ESTIMATES (HWAY-NASDAQ) SUMMARY

Trailing PE -- Forward PE -- NA 0 Analysts. 1-Year Return: 424.7% 5-Year Return: 415.2%

SCHV Schwab U.S. Large-Cap Value ETF

Torchmark Corp. NEUTRAL ZACKS CONSENSUS ESTIMATES (TMK-NYSE) SUMMARY

Trailing PE 4.0. Forward PE Buy 26 Analysts. 1-Year Return: -16.6% 5-Year Return: -60.3%

Kensington Analytics LLC. Convertible Income Strategy

IVE ishares S&P 500 Value ETF

Trailing PE Forward PE -- Hold 1 Analyst. 1-Year Return: 8.6% 5-Year Return: 66.9%

52-Week High Trailing PE Week Low Forward PE Buy 15 Analysts. 1-Year Return: 26.7% 5-Year Return: -1.

Trailing PE 4.8. Forward PE 8.6. Buy 2 Analysts. 1-Year Return: -10.6% 5-Year Return: 61.4%

Trailing PE Forward PE Hold 18 Analysts. 1-Year Return: 28.7% 5-Year Return: 63.9%

ABX's current average score is relatively in-line with the market. Peers MUX 4 RGLD 4 NEM 4 AEM 2

Trailing PE 8.4. Forward PE Buy 13 Analysts. 1-Year Return: 40.6% 5-Year Return: 152.2%

Analyst's Notes. Argus Recommendations

VLUE ishares Edge MSCI U.S.A. Value Factor ETF

PSI Invesco Dynamic Semiconductors ETF

Trailing PE Forward PE Buy 11 Analysts. 1-Year Return: 3.0% 5-Year Return: -19.7%

SPYV SPDR Portfolio S&P 500 Value ETF

Trailing PE -- Forward PE Buy 19 Analysts. 1-Year Return: -23.4% 5-Year Return: -40.6%

Transocean Ltd. NEUTRAL ZACKS CONSENSUS ESTIMATES (RIG-NYSE)

Total

SPDR Sector Scorecard

All data published in this report is available on FactSet. Please contact or FACTSET for more information.

FJP First Trust Japan AlphaDEX Fund

PERFORMANCE STUDY 2013

Trailing PE -- Forward PE -- Hold 13 Analysts. 1-Year Return: -7.6% 5-Year Return: -89.4%

PSET Principal Price Setters Index ETF

Trailing PE Forward PE -- NA 0 Analysts. 1-Year Return: -9.9% 5-Year Return: --

Trailing PE Forward PE Buy 13 Analysts. 1-Year Return: -10.6% 5-Year Return: -9.1%

Trailing PE Forward PE Hold 27 Analysts. 1-Year Return: 0.9% 5-Year Return: -20.5%

(PGR-NYSE) Risk Level *

Trailing PE -- Forward PE -- Hold 12 Analysts. 1-Year Return: -42.0% 5-Year Return: -74.6%

Trailing PE 6.0. Forward PE 5.4. Buy 9 Analysts. 1-Year Return: -18.2% 5-Year Return: 62.9%

Trailing PE Forward PE -- NA 0 Analysts. 1-Year Return: 26.2% 5-Year Return: 263.1%

PKB Invesco Dynamic Building & Construction ETF

Trailing PE Forward PE -- Buy 3 Analysts. 1-Year Return: 1.8% 5-Year Return: -5.4%

ITOT ishares Core S&P Total U.S. Stock Market ETF

Trailing PE Forward PE Buy 3 Analysts. 1-Year Return: -35.3% 5-Year Return: 339.3%

Trailing PE Forward PE -- Buy 16 Analysts. 1-Year Return: -69.4% 5-Year Return: -89.4%

DWAS Invesco DWA SmallCap Momentum ETF

DESC Xtrackers Russell 2000 Comprehensive Factor ETF

Low Correlation Strategy Investment update to 31 March 2018

Strong Buy 1 Analyst

First Quarter. January March 2016

OUT OF THE WOODS? COMMENTARY STRONG FUNDAMENTALS KEY TAKEAWAYS LPL RESEARCH WEEKLY MARKET. February

Analyst's Notes. Argus Recommendations

RWR SPDR Dow Jones REIT ETF

Trailing PE -- Forward PE Hold 31 Analysts. 1-Year Return: -12.6% 5-Year Return: 38.9%

52-Week High Trailing PE Week Low Forward PE -- NA 0 Analysts. 1-Year Return: -1.8% 5-Year Return: 3.6%

MITEL NETWORKS CORP (MNW-T) Software & IT Services / Software & IT Services / Software

An introduction to Invesco s Equity Long/Short Strategies

Detailed Stock Report

Trailing PE Forward PE Buy 12 Analysts. 1-Year Return: 13.9% 5-Year Return: 147.0%

Disciplined Stock Selection

SPDR Sector Scorecard

52-Week High Trailing PE Week Low Forward PE Buy 8 Analysts. 1-Year Return: 1.1% 5-Year Return: 73.1%

Lincoln Electric Holdings Inc.

Transcription:

Stock Fundamentals as of January 19, 10 Rating Strong Sell Ticker HCP Market Cap Designation Large-cap Market Capitalization (Billions) $9.2 Price $31.29 52-Week High/Low $33.45/14.93 EPS (TTM) $0.31 P/E Ratio (TTM).9 Dividend Yield 5.9% S&P 500 P/E Ratio 36.1 Price/Book Ratio 1.6 Price/Sales Ratio 8.1 30-Day Average Volume (Millions) 3.1 Beta 1.44 Current Ratio N/A Short Interest Ratio 7.6 Shares Outstanding (Millions) 293.1 Ratings 's Buy/Hold/Sell ratings are based on a combination of dynamic filters that determine which attributes of a stock are most predictive in the prevailing market and which stocks best reflect those attributes but are not yet rewarded. starts with an "extraction" process that uses the best performing filters to identify stocks having certain compelling attributes currently sought by the market. Then, a composite scoring process uses a weighted average of several key scores to quantify the relative likelihood of upside or downside price action. As a result, the Buy/Hold/Sell rating may, in certain cases, seem inconsistent with a simple average of the scores cited in this analysis. A BUY rating means the stock is expected to outperform its relevant benchmark substantially over the next 6 months. A rating means the stock is expected to underperform its relevant benchmark substantially over the next 6 months. A HOLD rating means the stock is expected to perform in line with its relevant benchmark over the next 6 months. If a stock is rated HOLD, the investor should review the stock's history of ratings to see if it has recently changed to HOLD from BUY or. If so, this indicates one of the following: (1) there has been a significant change in the stock's fundamentals, (2) the stock is already appropriately rewarded or punished by the market, or (3) there simply has been some recent price consolidation that warrants attention. A reading of 's analysis should identify which it is. More about on Page 4 $ $30 $ 15 10 5 Average Daily Volume in Millions Feb '09 Mar Apr MayJun Jul Aug Sep Oct Nov Dec Jan '10 Feb Mar Apr MayJun Jul Company Profile 50-Day Moving Average Aug Sep Oct Nov Dec Health Care Property Investors, Inc. operates as a real estate investment trust in the United States. The company, through its subsidiaries and joint ventures, invests in health care-related properties and provides mortgage financing on health care facilities. Earnings and Revenue Update: For the quarter ended September 30, 09, Health Care reported earnings of $-54.7 million or $-0.19 per share compared with $.0 million or $0.23 per share for the prior quarter and $88.6 million or $0.36 per share for the same quarter one year ago. Revenues were $296.6 million for the quarter ended September 30, 09 compared with $297.9 million for the prior quarter and $331.4 million for the same quarter one year ago. Last twelve months' earnings were $0.31 per share compared with $0.75 per share a year ago. Last twelve months' revenues were $1.1 billion compared with $1.2 billion a year ago. Analysis rates HCP a Strong Sell based on its overall inferior scores on important metrics that point to weak future market performance. Value: Based on a Value Score of 21.7, HCP is an improbable candidate for traditional value investors. A score in this range indicates that the stock price more than adequately values the company's historical and projected earnings. Growth: HCP's score of 50.1 for the Growth Score indicates that the stock's growth prospects are somewhat above average. Momentum: HCP posts a solid Momentum Score of 79.4. This score reflects price, earnings and group momentum. Timeliness: This stock has a Timeliness Score of 70.3. This is a composite measure of short-term and long-term price performance and long-term group performance. 's Market Cap Designations Large Cap Mid Cap Small Cap Micro Cap > $5.0 Billion $1.0 - $5.0 Billion $150 Million - $1.0 Billion < $150.0 Million Report prepared on January, 10 Page 1 Analysis continued on Page 3

Current Scores Compared with Industry and Relevant Benchmark These scores compare various aspects of with its industry and relevant benchmarks. The scores are percentile rankings from 0 to 99.9. Higher scores are better. We use a weighted average of several key scores to quantify the relative likelihood of upside or downside price action. Therefore, the rating may seem inconsistent with a simple average of the scores cited in this analysis. Growth Score: 50.1 HCP 50.1 Industry 41.3 sp500 53.8 Value Score: 21.7 HCP 21.7 Industry 29.0 sp500 51.8 Momentum Score: 79.4 HCP 79.4 Industry 64.1 sp500 45.4 Earnings Score: 29.2 HCP 29.2 Industry 36.3 sp500 48.2 Balance Sheet Score: 22.8 HCP 22.8 Industry 38.1 sp500 53.2 Fundamental Score: 30.7 HCP 30.7 Industry 41.3 sp500 57.8 The Growth Score reflects a company's historical and projected earnings growth, revenue and sales growth, projected cash flow, analyst activity, and changes in earnings estimates, each over various time periods. The higher the score, the better the combined performance of these key measures. With a Growth Score of 50.1, Health Care is marginally higher than the average of its industry group, which has a Growth Score of 41.3. The Value Score measures the relationship between a company's stock price and its intrinsic value, as indicated by earnings and balance sheet attributes, with an emphasis on earnings. Also considered are cash flow measures and fundamental valuation ratios. With a Value Score of 21.7, Health Care is marginally lower than the average of its industry group, which has a Value Score of 29.0. The Momentum Score measures a company's earnings and price momentum, evenly weighted, and augmented by group strength, money flow, and relative volume. Core technical factors include current price relative to periodic highs and moving averages. With a Momentum Score of 79.4, Health Care is moderately higher than the average of its industry group, which carries a Momentum Score of 64.1. The Earnings Score assesses a company's overall earnings performance and projected outlook. Time periods include an average look-back of three years with an emphasis on the past four quarters and a forward look of one to five years. With a Earnings Score of 29.2, Health Care is marginally lower than the average of its industry group, which has a Earnings Score of 36.3. The Balance Sheet Score measures a company's liquidity and debt issues, as well as receivables and inventory quality. This score is used to assess relative risk associated with a stock: the lower the score, most likely the higher the inherent risk. With a Balance Sheet Score of 22.8, Health Care is moderately lower than the average of its industry group, which carries a Balance Sheet Score of 38.1. The Fundamental Score is the broad measure of a company's financial health, including its balance sheet, cash flow, revenue, and earnings quality. With a Fundamental Score of 30.7, Health Care is moderately lower than the average of its industry group, which carries a Fundamental Score of 41.3. Timeliness Score: 70.3 HCP 70.3 Industry 58.3 sp500 50.3 The Timeliness Score is an assessment of a stock's short and long-term price strength as determined by various chart-based indicators and measures of group momentum and relative price performance. With a Timeliness Score of 70.3, Health Care is moderately higher than the average of its industry group, which carries a Timeliness Score of 58.3. Peer Analysis This table compares HCP with other similar-sized companies in the same industry group, focusing on 's growth, momentum and value scores, which represent the three main investing styles. The Peer Analysis chart compares HCP's 2-year total return with the average 2-year total return of these companies. 2-Year Total Return 25% -25% -50% 09 Report prepared on January, 10 Page 2 HCP Peers Symbol Company Growth Score Momentum Score Value Score Market Cap.(B) PSA Public Storage 46.5 73.2 14.1 $13.7 HCP 50.1 79.4 21.7 $9.2 HST Host Hotels 9.9 77.8 12.9 $7.7 VTR Ventas 66.7 92.0 5.1 $7.1 PCL Plum Creek 27.2 85.9 17.2 $6.3 HCN Health Care REIT 48.5 61.0 15.6 $5.6 NHP Nationwide Health 57.7 66.3 28.5 $4.2

Historical Scores The recent histories of key scores provide insight into the stock's trends -- whether they are increasing or decreasing in strength in a particular area or simply holding steady. The scores are percentile rankings from 0 to 99.9, with higher scores better. Keep in mind that ratings may seem inconsistent with a simple average of these key scores because a weighted average of several key scores is used to quantify the relative likelihood of upside or downside price action. Growth Score: 50.1 66.1 63.5 1/13/09 7/14/09 10//09 Current Value Score: 21.7 29.4 82.1 50.1 1/13/09 7/14/09 10//09 Current Momentum Score: 79.4 67.3 63.8 41.1 15.2 21.7 10//09 11/17/09 12/15/09 Current Earnings Score: 29.2 46.9 65.2 82.9 79.4 1/13/09 7/14/09 10//09 Current Balance Sheet Score: 22.8 33.2 26.3 52.6 29.2 1/13/09 7/14/09 10//09 Current Fundamental Score: 30.7 28.4 38.0 21.0 22.8 1/13/09 7/14/09 10//09 Current Timeliness Score: 70.3 31.2 30.7 Analysis continued from Page 1 Best Performing Filters: To determine the likelihood of near-term performance, builds and backtests "Smart Filters" to establish which caps, styles and attributes are drawing a premium in today's market. Currently, the three most predictive filters for the relevant segment are: Consistency Filter: The Consistency Filter measures various earnings trends, along with short-term revenue growth. High scores are given to stocks that exhibit a smooth expansion in earnings and notable short-term revenue growth. The filter is currently among 's best performers in the large-cap segment. HCP scores.0 for this filter. Composite Growth Filter: The Composite Growth Filter includes long-term and short-term factors related to earnings, cash flow and revenue growth. The filter has significantly outperformed its large-cap benchmark over the past three months. HCP scores 47.2 for this filter. Group Momentum Filter: The Group Momentum Filter measures industry group performance in multiple periods with an emphasis on the last three months and serves as a proxy for broader market sentiment toward a group or niche. Backtesting shows that the filter has earned a significant premium to its large-cap benchmark over the past three months. HCP scores 75.0 for this filter. In summary, HCP's Strong Sell rating is based on a profile of forward-looking metrics which show this stock could significantly underperform the broader markets. What the Market Wants: January 10 [Note: For email delivery of the weekly What the Market Wants, sign up at www.sabrient.com. To view this week's stocks ideas and market stats, see "What the Market Wants" at the blog at http://www.sabrient.com/blog/.] A WEEK OF MURK AND FOG By David Brown, Chief Market Strategist (January 19, 10) Last week brought us murk and fog in an otherwise bright New Year. All style/caps were down for the week, though not drastically. The worst was Small-cap Growth (- 1.12%); the best was Large-cap Growth (-0.6%); and the rest crowded between these uninspiring returns. But given the tremendous amount of cash on the sidelines, the market seems unlikely to turn disastrous. It could have been worse. Alcoa (NYSE: AA), Monsanto (NYSE: MON) and Chevron (NYSE: CVX) disappointed badly early on, although Intel (Nasdaq: INTC) brought in pleasing numbers later in the week. Government statistics were for the most part dismal -- worse-than-expected numbers for trade balance (-36.4 B), initial job claims (+11,000 to 444,000) and retail sales (-0.3%). Even consumer sentiment was poor (flat, actually, at 72.8 vs. December's final 72.5), probably a reflection of the other disappointing statistics. Only the consumer price index (CPI) was encouraging, increasing just 0.1% in December, after a 0.4% rise in November. Although Europe is beginning to struggle with inflation, the U.S. isn't having that problem yet. 57.8 66.7 63.6 70.3 10//09 11/17/09 12/15/09 Current Report prepared on January, 10 Page 3

This morning's announcement by Citigroup (NYSE: C) was worse than ugly, but it met expectations and still closed higher. IBM (NYSE: IBM) beat estimates but sold off a bit afterhours. Google (Nasdaq: GOOG) reports on Thursday. It must be the glow of these giants, plus all that money on the sidelines, that has the market doing so well, even as it reflects on last week's mess. Indeed, the S&P 500 closed at a new 52-week high today, with the Dow and the Nasdaq closing in on theirs. A bit surprising is that all of today's positive activity is in spite of a stronger dollar. Perhaps part of the market's resilience is due to several major M&A events, highlighted by Tyco's (NYSE: TEL) purchase of Brinks (NYSE: BCO). I guess if you can't rob the truck, just buy it. Our sector outlook for last week had Healthcare, Consumer Staples, and Utilities in the top 5, and it was close to spot on as those three sectors were three of the only four sectors positive for the week. Materials, as predicted in our January 8th SectorCast, brought up the bottom last week, with Energy and Financials not much better. This week, the outlook seems best for Telecom, Healthcare and Utilities and worst for Materials, Industrials and Financials. As you can see from the SectorCast table, the Financials sector has fallen to the bottom once again. Caution remains the word of the day, although the significant cash on the sidelines seems unlikely to let the market slip too much, barring any unforeseen disaster. To see this week's stock ideas and market stats, go to the blog at http://www.sabrient.com/blog/.] Next update: Monday, January 25, 10. Company Description Health Care Property Investors, Inc. operates as a real estate investment trust in the United States. The company, through its subsidiaries and joint ventures, invests in health care-related properties and provides mortgage financing on health care facilities. It acquires health care facilities and leases them to health care providers. As of December 31, 05, the company's real estate portfolio, including properties held through joint ventures and mortgage loans, consisted of interests in 527 facilities located in 42 states. Its properties include senior housing facilities, medical office buildings, hospitals, skilled nursing facilities, and other healthcare facilities, including laboratory and office buildings. Health Care Property Investors has elected to be treated as a REIT for federal income tax purposes and would not be subject to income tax, if it distributes approximately 90% of its taxable income to its share holders. The company was founded in 1985 and is headquartered in Long Beach, California. About Systems is an independent research firm providing statistical analysis of a company's fundamental data to investment professionals. We use a computer-driven, quantitative methodology to identify stocks that appear poised to outperform or underperform the market. The methodology was developed by an experienced research team led by David Brown, a former NASA scientist and retired CEO of Telescan and designer of its premier stock search program, ProSearch. The research team employs a scientific approach to the creation and testing of multi-factor filters. Each filter targets a key area of traditional stock analysis, including value, growth, momentum, fundamentals, earnings, balance sheet, and group strength. Using an adaptive process, filters are continually tested and monitored to ensure that only the best performing filters are at work. 's ratings begin with an extraction process in which each of the few best-performing filters scans the universe of equities to identify stocks having certain compelling attributes sought, but not sufficiently rewarded, by the current market. Then, a composite scoring system employs a broader set of "weighting" filters to rank the extracted stocks. To support individual investors, uses the same sophisticated methodology to provide individual stock reports on a universe of approximately 5,0 stocks. regularly tests the performance of its stock selections, using its primary list of published rankings and statistical techniques it believes appropriate. These recommendations have consistently outperformed relevant benchmarks across a broad range of investing styles, market caps, time frames and market conditions, demonstrating the robustness of 's proprietary methodology. While past performance is no guarantee of future results, believes it can maintain its strong performance through its rigorous, scientific approach to filter construction and ongoing backtesting within a dynamic and adaptive composite scoring system. For more information on and its performance, go to www.sabrient.com Report prepared on January, 10 Page 4

Disclaimer SmartStock research is provided for informational purposes only. It is neither a solicitation to buy nor an offer to sell these securities. The report is based upon data from sources believed to be reliable, but makes no representation as to the data's adequacy, accuracy, completeness or timeliness. The report does not address individual investment objectives or financial situations. The analysis used in preparing these reports may also be used in the preparation of other research products which may reflect distinct investment objectives. accepts no liability for any loss arising from any use of this report. This report is based solely on mathematical calculations and does not reflect any bias of individual analysts. provides no investment banking, consulting or other services to the subject company of this report. No employee is on the Board of Directors of the subject company, and no one at the subject company serves on the Board of Directors of Systems. or its employees may have long or short positions in the securities or other related investments of the company mentioned herein, but never more than one percent (1%) of the outstanding shares of any company covered by. No part of this document may be reproduced without the written permission of Systems. Report prepared on January, 10 Page 5